env Antibody

Datasheet

Code	CSB-PA883290XA01FYY
Size	US$299
Image	Western Blot Positive WB detected in: recombinant protein All lanes:env Antibody at 1:1000 Secondary Goat polyclonal to rabbit IgG at 1/20000 dilution Predicted band size: 42.3 kDa Observed band size: 46 kDa Exposure time: 10s.
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Full Product Name

Rabbit anti-Koala retrovirus (KoRV) env Polyclonal antibody

Uniprot No.

Q9TTC0

Target Names

env

Alternative Names

Envelope glycoprotein (Env polyprotein) [Cleaved into: Surface protein (SU) (Glycoprotein 70) (gp70); Transmembrane protein (TM) (Envelope protein p15E); R-peptide (p2E)] env

Raised in

Rabbit

Species Reactivity

Koala retrovirus (KoRV)

Immunogen

Recombinant Koala retrovirus (KoRV) env protein (44-257aa )

Immunogen Species

Koala retrovirus (KoRV)

Conjugate

Non-conjugated

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form

Liquid

Tested Applications

ELISA, WB

Recommended Dilution

Application	Recommended Dilution
WB	1:500-1:5000

Protocols

ELISA Protocol
Western Blotting(WB) Protocol

Troubleshooting and FAQs

Antibody FAQs

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Lead Time

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function

The surface protein (SU) attaches the virus to the host cell by binding to its receptor. This interaction triggers the refolding of the transmembrane protein (TM) and is thought to activate its fusogenic potential by unmasking its fusion peptide. Fusion occurs at the host cell plasma membrane.; The transmembrane protein (TM) acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm.

Subcellular Location

[Transmembrane protein]: Virion membrane; Single-pass type I membrane protein. Host cell membrane; Single-pass type I membrane protein.; [Surface protein]: Virion membrane; Peripheral membrane protein. Host cell membrane; Peripheral membrane protein.; [R-peptide]: Host cell membrane; Peripheral membrane protein.

Promotions

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Neutralizing Antibody Stands Out Among Antiviral Therapies Oncogenes and Cancer GPC3: The Next-Promising Target in Cancer Immunotherapy What Are Histones: Unraveling Their Critical Roles in Disease Pathogenesis Does Antibody-dependent Enhancement Occur in SARS-CoV-2 Infection? Decoding the Biological Complexity of Endometrial Cancer: Essential Insights for Researchers Melanoma, the Most Serious Type of Skin Cancer Multiple Myeloma, One of High-Risk Factors for COVID-19 Non-Hodgkin's Lymphoma, One of Common Heterogeneous Malignant Tumors STAT3: a Key Transcriptional Regulator in Cancer MUC16 (CA125): a Promising Predictive Marker and Therapeutic Target in Cancer Two Types of Macrophages: M1 and M2 Macrophages An Overview of Cell Death: Necrosis and Apoptosis TNFR1: Elucidating Dual Mechanisms and Evolving as a Precision Therapeutic Target CCR8: a Specific Marker on Tregs Cells, the Next Promising Candidate for Antitumor Drugs! C5AR1: A Potential Molecule of Complement System to Fuel COVID-19 Therapy! Lysosomal Enzymes and Lysosomal Storage Disorders (LSDs) 2021 Insights on the CAR-T Cell Therapy: the Most Popular Targets for Solid Tumor! Cellular Senescence and Its Markers How to Properly Reconstitute Lyophilized Proteins? Does LIF Only Play a Role in Leukaemia? DNA Damage and Repair Chemokine Receptor CCR4: the Key Role of CCR4+Treg Cells in Cancer Immunotherapy Streamlining Antibody Internalization Assessment with DT3C: Accelerating ADC Candidate Selection PTPRD: The Overlooked Signaling Hub from Neurodevelopment to Cancer Suppression Recombinant Monkeypox Virus Proteins - Accelerate Monkeypox Research CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2! DDR1: a Novel Member of the RTKs Family, a Potential Target for Tumor Therapy! RSPO1: The key factor determining "battle of the sexes " is “favored” in the culture of organoids? CD93, A Rising Star in Anti-Tumor Therapy Intestinal Mucosal Barrier Bodyguard --ALPi The Collection of Progress of Anti-GPCR Antibody Drugs Dual Role of TNFRSF14 in Immunology CD31- A Complex Function Molecule Surface Markers That Help You Identify Lymphocytes Cell Differentiation Determines the Fate of Cells Twice Halted in One Year! Is Akeso's CD73 Monoclonal Antibody in Jeopardy Again? Is PD-1's Golden Partner Still Worth It? Exploring Biological Landscape of Cervical Cancer: A Comprehensive Overview for Researchers Immune Activation: Insights into T Cell Differentiation A Comprehensive Overview of Ovarian Cancer SLC7A11: a New Potential Therapeutic Target via Induced Ferroptosis in Tumors! Protein Phosphorylation: The Dynamic Language of Cellular Regulation Differentiation of Th17 Cells and Their Roles in Health and Disease ULBP1: a Potent Member of NKG2D Ligands in CAR-T Therapy for Multiple Hematological and Solid Tumors! How to Choose the Loading Control Antibodies? Microglial Markers: Insights into Microglial Activation and Function Homeobox Transcription Factor- NANOG How to Inquire and Utilize the Signal Pathway on KEGG 63.9% Objective Response Rate! B7-H3 Targeted Therapy Transforms Small Cell Lung Cancer Treatment, Domestic Players Compete in Hundred-Billion-Yuan Market The Overview of Recombinant Antibody DSG2: a Vital Member of Desmosomal Cadherin Family, an Exciting New Target for Cardiomyopathy, Adenovirus, and Tumors! MYL9: a New Member of Myosin Motors, a Key Driver of Cancer Cell Dynamic Regulation? ZG16B: A New Tumor Biomarker Offers Important Insights for Drug Development in Pancreatic Cancer! New Mechanism, NRP1 Enhances the Ability of SARS-CoV-2 Infection Leukemia, Why is it So Common? CEACAM8: a Member of CEA Family, Emerging as a Vital Player in Gynaecological or Gastrointestinal Cancer Research! Biological Activity of Proteins The Overview of Cell Viability The Metabolic Phenotype of Tumor-Associated Macrophages in the Tumor Microenvironment Stem Cell-What a Miraculous Resource in Human Body IL-6-Do You Really Know That? Nanobody, what a Powerful Novel Antibody! What Do You Need to Know Before Researching Human Metapneumovirus? CD147, a New Target of SARS-CoV-2 Invasion DKK1: a Well-Characterized Wnt Inhibitor, a Multifunctional Regulator in Multiple Cancers! One World, One Hope——What Can We Do about AIDS? Toll-like Receptors--The Eye of Innate Immunity A Comprehensive Exploration into Amyotrophic Lateral Sclerosis Do you Often Trouble in These Problems of ELISA? What Factors Could Affect ELISA Results? A "trembling" Parkinson's Disease What Is Immune Checkpoint Therapy? What Are Immune Checkpoint Inhibitors? Focus on Emerging Therapeutic Targets BCMA What Are Immune Checkpoint Pathways? Hematopoietic Stem Cell Surface Marker Tumor Necrosis Factor Receptor Superfamily and Apoptosis The Power and Promise of Stable Cell Lines Understanding of Serum Albumin Monoclonal Antibody Drugs Overview SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! What You Have To Know about Lung Cancer Protein Kinases Overview: Definition, Types, Function, Activation Mechanism, etc. The Overview of Hippo Signaling Pathway Exploring Neurodegeneration: A Comprehensive Guide for Researchers The Recently Emerged New Swine Influenza Virus -- G4 EA-H1N1 How do Th1 and Th2 Cells Differentiate? What Powerful Model Organism Databases Protein Tyrosine Kinases: Anti-tumor Targets to be Explored Urgently TCGA Database- A Good Partner of Researchers Unraveling the Dynamic World of Histone Modifications: Implications in Gene Regulation and Disease Pathogenesis Identify Treg Cells. You Can Do This. The Multifunctional Enzyme CD38: A Target for Immunotherapeutic Approaches in Cancer About Thyroid Tumor: Essential Information for Researchers What A Paradoxical TNF Signaling Pathway-Based on Different Receptors What Essential Biological Knowledge is Needed for Hepatocellular Carcinoma Research? These Tumor Databases You Have To Know CD146, A Powerful Tumor Marker GPCR Drugs Discovery Introduction of Hepatocellular Carcinoma Related Signaling Pathways SIGIRR: A Novel Member of the TIR Superfamily Acts as the Anti-Inflammatory 'Brake' to Control Immune Response in Various Diseases! Mesothelin: A Rising Star of Cancer Immunotherapy CD70 (CD27L/TNFSF7): a TNF Receptor Member, a “Star” Target for Clinical Research in Systemic Lupus Erythematosus (SLE), Arthritis, and Tumors! Diabetes: What You Need to Know Before Starting Research? ACE2, The Hottest Target of SARS-CoV-2 Invasion PD-1-- An Important Immune Checkpoint An Overview of CD226 and Its Promising Role in Cancer Immunotherapy OMA1-A Potential Cancer Therapy Target CD Antigens - From Leucocytes Surface Markers to Diagnostic Markers for Cancer TASIN represents a promising approach for prevention of colorectal cancer TM4SF1: a Member of the Transmembrane-4-Superfamily (L6), a New Vascular Therapeutic Target? LY6G6D (LY6-G): A New Member of Lymphocyte Antigen-6 Family Holds Big Opportunities in Bispecific Antibody for CRC Treatment! Exploring the Science of Influenza A Virus: What You Need to Know Applications of recombinant proteins ANGPT2 (Ang-2): the First Bispecific Antibody for Eye Vision Loss Therapy, a Novel Target for Tumor Angiogenesis! Norwalk Virus Another powerful addition to domestic IL-17A inhibitors! 3S Guojian's Anmoqitamab approved, with once-every-8-week dosing—a game-changer for psoriasis patients. The Overview of Colony Stimulating Factors Apoptosis mediated by mitochondria PD-1/PD-L1, What a Powerful Immune Checkpoint EphA3-A Regulator of Cell Adhesion and Migration The Memory thief - Alzheimer's disease The Overview of Interferon Cell Cycle Markers in Focus: From Basic Research to Biomarker Discovery in Oncology The Overview of Organelles The Overview of Autophagy The Four Types of ELISA: Principles, Innovations, and Evolving Applications Production of Recombinant Protein Phage Display: From Antibody Discovery to Therapeutic Breakthroughs Crosstalk Between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer The overview of TGF-β signaling pathway The Encyclopedia of Common Virus Double-Edged Sword: TGF-β CCR9: A Member of the Chemokine Receptor Family, an Emerging Target for Numerous Tumor Researches! Chemokine Receptor CCR6: the Specific Receptor for CCL20, a Potential Target for Drug Research in Inflammatory Diseases and Gastrointestinal Cancer! CEACAM6: a Potent CEA Family Molecule, a New Tumor Marker or Anti-Cancer Target! What Is Tomato Mosaic Virus What Should You Know about Exosomes? The Review of Post-translational Modifications CXCR4: An Attractive Target of GPCR family Brings Promising New Drugs for Cancer Therapy！ GUCY2C: a Novel Target in Tumor Immunotherapy, Specially in Colorectal Cancer CAR T Therapy! SEMA4D/CD100: As an Important Immunoregulator to Improve Immunotherapy SSTR2: A Prominent Target in SSTR Family, Offers a More Precise Therapy in Neuroendocrine Tumors (NET) CADM1: an Immunoglobulin Superfamily Molecule, a New Tumor Suppressor Gene! Oncostatin M (OSM): A Member of IL-6 Cytokine Family, An Underestimated Player in Future Targeted Therapies? Targeting LRRC15: From tumor microenvironment regulation to fibrotic/infectious disease therapy In Vivo vs. In Vitro: Choosing the Right Experimental Model for Your Research Dipeptidase 3 (DPEP3): an Emerging Member of the DPEP Family, a Potential Therapeutic Target in Male Fertility or Tumor Research! Exploring Protein-Protein Interactions: A Comprehensive Guide to Understanding and Utilizing It IL-6: an Important Participant in the Inflammatory Cascade, One of the Most Functional Cytokines in Various Diseases Research! CT83/KK-LC-1: a Promising Therapeutic Target of CTAs Family, Currently in Clinical Research for Breast, Lung, Gastric Cancers, and Beyond! What is a His Tag? A Guide from Definition to Applications Nectin-4: a Key Target in the IgSF Family, Boosting Clinical Drug Research in Various Tumors! T Cell Activation - The Switch for T Cell Executive Function Major Start to 2026: Impressive Clinical Data for CDH6-Targeting ADC, with Domestic Follow-Ups Close Behind Glycolysis Pathway: The Essential Energy Source for Cells, Even in Low-Oxygen Conditions What Is Compartment Modelling in Pharmacokinetics? TIGIT Targeted Immunotherapies Offer New Hope for Cancer Treatment TNFSF15/TL1A: The Rise of the Next Billion-Dollar Target as Pharma Giants Stake Their Claims The Structure, Function, and Research Progress of Lymphotoxin β Receptor (LTBR) in Disease and Drug Development CSF2/GM-CSF: A Key Molecule in Immune Regulation and Disease Treatment TNFSF18: Unlocking New Frontiers in Cancer Immunotherapy IL-6: A Central Factor in Cytokine Storms and a Health Alert for Infections and Diseases TNFRSF13C (BAFF-R): A Key Target for Immune Regulation and Disease Treatment PVR (CD155): A Key Factor in Tumor Immune Evasion and a Novel Therapeutic Target How the Tumor Microenvironment Fuels Cancer's Deadly Evolution CEACAM1: An Emerging Multifunctional Target for Cancer-Immune Modulation DLL4: A Key Target for Angiogenesis Regulation Pioneering CAR-T Cell Therapy: Advancing Personalized Cancer Treatment How Do CTLA-4 Inhibitors Work? A Complete Guide for Early-Career Researchers IL2's 'Double-Edged Sword' Strikes Again: PD1/IL2/VEGF Trispecific Antibodies Emerge at AACR 2026, Nektar's Autoimmune Data Sparks Heated Discussion CCL17: A Chemokine with Multiple Biological Functions Immune Battlefield's "Scout": Decoding the NCR3 Target PTH1R: Key Therapeutic Target in Bone & Metabolic Health Colony Stimulating Factor 1 (CSF1): Its Key Role in Diseases and New Progress in Targeted Therapy B7-H6: A Key Ligand of NK Cell Immune Checkpoints Reshaping the Landscape of Tumor Immunotherapy MICB: a key molecule that bridges cellular stress and immune responses MICA: key regulatory molecule for tumor immune surveillance and its therapeutic target potential LYPD3: An Emerging Star in Solid Tumor Therapy TSLP: A Key Target in Allergic and Inflammatory Diseases LAG3: The Next Frontier in Tumor Immunotherapy Targeting the "Hidden Target" ROR1: A Breakthrough for Broad-Spectrum Cancer Therapy? FLT1 (VEGFR-1): A Bidirectional Regulator of Angiogenesis and an Emerging Therapeutic Target CD45: The Immune Cell "Gatekeeper" Protein – Why is it Emerging as a Novel Therapeutic Target? The Metabolic Achilles' Heel of Cancer Stem Cells: New Mechanism of LGR5 Reveals Metformin's Anticancer Potential SIGLEC15: An Emerging Immune Checkpoint Target in Tumor Immunotherapy Targeting TNFRSF13B: Dual-Target Strategies Usher in New Focus for Treating Tumors and Autoimmune Diseases In-depth Dialogue on the "Core Triangle" of Inflammation: How IL-6, IL-1β, and TNF-α Interact to Drive Disease Progression? Targeting EphA2: An Emerging Focus in Combating Tumor Drug Resistance and Metastasis Macrophage Migration Inhibitory Factor (MIF): A Pleiotropic Target Linking Inflammation and Cancer IL1RAP: Background, Research Mechanisms, Signaling Pathways, Related Diseases, and Latest Advances in Drug Development Groundbreaking! "Cancer Immunol Res": mRNA-LNP Targeting FAP Reprograms T Cells In Vivo, Outperforming Traditional CAR-T in Pancreatic Cancer BTLA: An Emerging Target in Immunotherapy – New Insights into Cancer and Autoimmune Diseases PDGFRA: A Hub in Cellular Signaling and a Therapeutic Target The Multifaceted World of ADAM9: Beyond Proteolytic Function CRLF2 (TSLPR): A Key Target Linking Type 2 Inflammation to Hematologic Malignancies FCGR3A: A Key Receptor for Immune Regulation 2026 Trends in Macromolecular Drug Targets: GLP-1 Deepening, Cardiovascular Remodeling, Immune Combinations, and the "Post-PD-1" Era Beyond PD-1? The Potential and Breakthroughs of the Emerging Immune Checkpoint BTLA ACVR1C/ALK7: An Emerging Target in Metabolic Diseases and Cancer Therapy ANGPTL3: From Mechanisms to Clinics, Exploring a Novel Therapeutic Target for Cardiometabolic Diseases Emerging Therapeutic Target ANGPTL4: A Key Molecule Linking Metabolism, Inflammation, and Tissue Remodeling From "Physical Barrier" to "Signaling Hub": How Mucin MUC1 Drives Tumor Progression Spanning Eight Major Cancers: Why Has Transmembrane Mucin MUC13 Become a New Focus in Precision Tumor Therapy? B2M/β2-Microglobulin: From Antigen Presentation Core to Key Target for Immunotherapy and Disease Prediction CDH1/E-cadherin: Research Progress on a Core Target from Adhesion Regulation to Tumor Therapy Overview of CCR4 Target: Core Roles in Physiological Functions and Pathological Regulation CD28: Molecular Mechanism and Therapeutic Progress of the Core Co-Stimulatory Receptor in T Cells CCN2 (CTGF) Target: Core Molecule of Fibrosis and Tumor Stroma Regulation | Disease Treatment Research Progress BTN3A1 (CD277) Target: γδ T Cell Immune Recognition Mechanism and Cancer Immunotherapy Research Progress CD4 Molecule: A Review of Structural Characteristics, T Cell Subsets, Signaling Pathways, Disease Associations and Progress in Targeted Drug Development CD33 (Siglec-3) Signaling Pathways and Disease Mechanisms: Roles in Acute Myeloid Leukemia, Alzheimer’s Disease and Immune Regulation CD19: Molecular Mechanisms, Disease Associations and Progress in Targeted Therapy CD40LG: A Key Molecule in Immune Regulation, Disease Associations and Therapeutic Progress Fibroblast Growth Factor 2 (FGF2): Molecular Mechanisms, Signaling Pathways, Disease Associations and Therapeutic Advances CD74: From MHC II Chaperone to Therapeutic Target - Molecular Mechanisms, Disease Associations and Therapeutic Advances The CD200/CD200R Signaling Axis: A Critical “Brake” in Maintaining Immune Homeostasis Beyond PD-1/CTLA-4! The Emerging Immune Checkpoint CD160 is Transforming the Landscape of Tumor Immunotherapy Beyond PD-1: CD96 is Becoming the Next "Battleground" in Immunotherapy Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：
Please enter the characters shown. Click the image to refresh if unclear.

env Antibody

Product Details

Related Products

Customer Reviews and Q&A

Target Background